Guided Therapeutics (GTHP) Gross Margin Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26,237.00 |
| Sep 30, 2025 | -2,608.00 |
| Dec 31, 2024 | -27,500.00 |
| Mar 31, 2024 | -2,778.00 |
| Dec 31, 2023 | 15,476.00 |
| Jun 30, 2023 | -6,250.00 |
| Mar 31, 2023 | 3,409.00 |
| Sep 30, 2022 | 29,394.00 |
| Jun 30, 2022 | 7,425.00 |
| Mar 31, 2022 | 5,619.00 |
| Dec 31, 2021 | 2,944.00 |
| Sep 30, 2021 | -13,158.00 |
| Dec 31, 2020 | -204,889.00 |
| Sep 30, 2020 | 168,442.00 |
| Dec 31, 2019 | 4,423.00 |
| Sep 30, 2019 | 9,091.00 |
| Jun 30, 2019 | -576,364.00 |
| Mar 31, 2019 | 46,287.00 |
| Dec 31, 2018 | -5,736.00 |
| Sep 30, 2018 | 16,860.00 |
| Jun 30, 2018 | 8,885.00 |
| Mar 31, 2018 | 4,057.00 |
| Dec 31, 2017 | -21,437.00 |
| Sep 30, 2017 | -19,221.00 |
| Jun 30, 2017 | 1,077.00 |
| Mar 31, 2017 | -6,644.00 |
| Dec 31, 2016 | -7,160.00 |
| Sep 30, 2016 | -8,164.00 |
| Jun 30, 2015 | -113,453.00 |